This study demonstrated that the treatment with CA resulted in the decline of serum levels of NF-κB, NrF2, and IL-6 in PCOS rats which resulted in a reduced risk of chronic inflammation. The gene discussed is NFE2L2; the disease is polycystic ovary syndrome.